Atlas Trials

Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral Conjunctivitis

Clinical trial NCT03749317 · COMPLETED

Trial details

NCT number
NCT03749317
Sponsor
IVIEW Therapeutics Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Adenoviral Conjunctivitis
Start date
2023-02-20
Primary completion
2024-04-30
Enrollment
135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.